Related Experiment Video
Updated: Jun 10, 2026

Enhanced Crosslinking Immunoprecipitation (eCLIP) Method for Efficient Identification of Protein-bound RNA in Mouse Testis
Published on: May 10, 2019
P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages
Ryan Burdick1, Jessica L Smith, Chawaree Chaipan
1HIV Drug Resistance Program, National Cancer Institute-Frederick, Viral Mutation Section, Frederick, MD 21702, USA.
Abstract:
Recent studies have shown that APOBEC3G (A3G), a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) replication, is localized to cytoplasmic mRNA-processing bodies (P bodies). However, the functional relevance of A3G colocalization with P body marker proteins has not been established. To explore the relationship between HIV-1, A3G, and P bodies, we analyzed the effects of overexpression of P body marker proteins Mov10, DCP1a, and DCP2 on HIV-1 replication. Our results show that overexpression of Mov10, a putative RNA helicase that was previously reported to belong to the DExD superfamily and was recently reported to belong to the Upf1-like group of helicases, but not the decapping enzymes DCP1a and DCP2, leads to potent inhibition of HIV-1 replication at multiple stages. Mov10 overexpression in the virus producer cells resulted in reductions in the steady-state levels of the HIV-1 Gag protein and virus production; Mov10 was efficiently incorporated into virions and reduced virus infectivity, in part by inhibiting reverse transcription. In addition, A3G and Mov10 overexpression reduced proteolytic processing of HIV-1 Gag. The inhibitory effects of A3G and Mov10 were additive, implying a lack of functional interaction between the two inhibitors. Small interfering RNA (siRNA)-mediated knockdown of endogenous Mov10 by 80% resulted in a 2-fold reduction in virus production but no discernible impact on the infectivity of the viruses after normalization for the p24 input, suggesting that endogenous Mov10 was not required for viral infectivity. Overall, these results show that Mov10 can potently inhibit HIV-1 replication at multiple stages.
Insights
Mov10 protein potently inhibits human immunodeficiency virus type 1 (HIV-1) replication by affecting multiple stages, including virus production and infectivity. This suggests Mov10 is a key factor in controlling HIV-1.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- APOBEC3G (A3G) inhibits HIV-1 replication and localizes to cytoplasmic mRNA-processing bodies (P bodies).
- The functional significance of A3G's colocalization with P body proteins in HIV-1 replication remains unclear.
Purpose of the Study:
- To investigate the relationship between HIV-1, A3G, and P bodies.
- To determine the effect of overexpressing P body marker proteins (Mov10, DCP1a, DCP2) on HIV-1 replication.
Main Methods:
- Overexpression of P body marker proteins Mov10, DCP1a, and DCP2 in virus producer cells.
- Analysis of HIV-1 Gag protein levels, virus production, and infectivity.
- Assessment of Mov10 incorporation into virions and its effect on reverse transcription.
- Evaluation of the impact of Mov10 and A3G co-overexpression and Mov10 knockdown via siRNA on HIV-1 replication.
Main Results:
- Mov10 overexpression, but not DCP1a or DCP2, significantly inhibited HIV-1 replication at multiple stages.
- Mov10 overexpression reduced HIV-1 Gag levels, decreased virus production, and lowered virus infectivity by inhibiting reverse transcription.
- Both Mov10 and A3G overexpression reduced HIV-1 Gag processing, with additive inhibitory effects.
- siRNA-mediated knockdown of endogenous Mov10 reduced virus production but did not impact viral infectivity.
Conclusions:
- Mov10 is a potent inhibitor of HIV-1 replication, acting at multiple stages.
- Mov10's inhibitory effects on HIV-1 are distinct from those of A3G, suggesting no functional interaction.
- Endogenous Mov10 plays a role in regulating HIV-1 production but is not essential for viral infectivity.
More Related Videos
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Retrovirus Life Cycles
Negative Regulator Molecules
Retroviruses

